BioSpace News Archive

Deals

Brooks Acquires Laboratory Software Firm RURO Inc.

Brooks Automation, Inc. announced that it has acquired RURO, Inc., an informatics software company based in Frederick, Maryland.

February 11, 2020

·

4 min read

Business

Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET

Harvard Bioscience, Inc. will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on February 26, 2020, and will hold a conference call to discuss the results on February 26, 2020 at 8:00 a.m. Eastern Time.

February 11, 2020

·

1 min read

Biotech Beach

DermTech to Present at Upcoming Investor Conferences - Feb. 11, 2020

DermTech, Inc. announced that John Dobak, M.D., Chief Executive Officer of the Company, is scheduled to present at the following upcoming investor conferences

February 11, 2020

·

3 min read

Business

Decipher Biosciences Announces Addition of Dr. Robert S. Epstein as Chairman and Kathy Hibbs, Esq. to its Board of Directors

Decipher Biosciences announced the appointments of Robert S. Epstein, M.D., and Kathy Hibbs, Esq. to its Board of Directors. Dr. Epstein was also elected Chairman of the Board.

February 11, 2020

·

4 min read

Deals

Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock

Xeris Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a public offering price of $4.15 per share, before underwriting discounts and commissions and other offering expenses, for gross proceeds of approximately $37.4 million.

February 11, 2020

·

4 min read

Biotech Beach

Today Show Interview with Attorney Gregory L. Bentley Highlights Fight Against Allergan for its Defective, Recalled BIOCELL Textured Breast Implants

Gregory L. Bentley, co-founder of Bentley & More LLP, and his client Hilary Corts were interviewed by the Today Show to highlight Hilary’s ongoing legal battle with Allergan over the company’s defective and recalled BIOCELL textured breast implants.

February 11, 2020

·

2 min read

Deals

Moderna Announces Pricing of Public Offering of Shares of Common Stock - Feb. 12, 2020

Moderna, Inc. announced the pricing of an underwritten public offering of 26,315,790 shares of common stock at a public offering price of $19.00 per share, before underwriting discounts and commissions.

February 11, 2020

·

5 min read

Business

BerGenBio ASA: Results For The Fourth Quarter and Full Year 2019

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces its results for the fourth quarter and full year 2019.

February 11, 2020

·

6 min read

Policy

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review

FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping (METex14) mutated advanced non-small cell lung cancer (NSCLC)(1)

February 11, 2020

·

8 min read

Deals

Inotrem Expands Series B Financing to €58 Million With a Mix of Equity and Debt, Adding New Investors Fountain Healthcare Partners, Kreos and Bpifrance

New investor Fountain Healthcare Partners provides a further €5 M capital increase adding on the initial €39 M announced last September.

February 11, 2020

·

5 min read